SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0000318771-07-000010
Filing Date
2007-05-04
Accepted
2007-05-03 21:24:15
Documents
8
Period of Report
2007-03-31

Document Format Files

Seq Description Document Type Size
1 GENENTECH, INC. FORM 10-Q FOR THE PERIOD ENDING 03/31/2007 dna-10q_0107.htm 10-Q 1039287
2 FOURTH AMENDMENT TO THE MANUFACTURING AND SUPPLY AGREEMENT BETWEEN GENENTECH AND ex10_1.htm EX-10.1 35400
3 AMENDMENT NO. 1 TO THE GENENTECH, INC. TAX REDUCTION INVESTMENT PLAN, AS AMENDED ex10_2.htm EX-10.2 43937
4 AMENDMENT NO. 2 TO THE GENENTECH, INC. TAX REDUCTION INVESTMENT PLAN, AS AMENDED ex10_3.htm EX-10.3 16622
5 LETTER REGARDING UNAUDITED INTERIM FINANCIAL INFORMATION ex15_1.htm EX-15.1 5366
6 CERTIFICATION OF CHIEF EXECUTIVE OFFICER PURSUANT TO RULES 13A-14(A) AND 15D-14( ex31_1.htm EX-31.1 12655
7 CERTIFICATION OF CHIEF FINANCIAL OFFICER PURSUANT TO RULES 13A-14(A) AND 15D-14( ex31_2.htm EX-31 12975
8 CERTIFICATIONS OF CHIEF EXECUTIVE OFFICER AND CHIEF FINANCIAL OFFICER PURSUANT T ex32_1.htm EX-32.1 11729
  Complete submission text file 0000318771-07-000010.txt   1179363
Mailing Address 1 DNA WAY . SOUTH SAN FRANCISCO CA 94080
Business Address 1 DNA WAY SOUTH SAN FRANCISCO CA 94080 650-225-1000
GENENTECH INC (Filer) CIK: 0000318771 (see all company filings)

IRS No.: 942347624 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-09813 | Film No.: 07817594
SIC: 2834 Pharmaceutical Preparations